NasdaqGS - Nasdaq Real Time Price • USD
TherapeuticsMD, Inc. (TXMD)
As of 12:48 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -3.13 | 8.23 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 500k | 502k | 1.3M | 9M |
| Low Estimate | 500k | 600k | 2M | 9M |
| High Estimate | 500k | 600k | 2M | 9M |
| Year Ago Sales | 20.92M | 1.15M | 69.96M | 1.3M |
| Sales Growth (year/est) | -97.60% | -56.40% | -98.10% | 591.20% |
Earnings History
| CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 3/31/2023 | 6/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.57 | -1.11 | 0.06 | -0.07 |
| EPS Actual | -3.13 | 8.23 | -0.37 | -0.24 |
| Difference | -2.56 | 9.34 | -0.43 | -0.17 |
| Surprise % | -449.10% | 841.40% | -716.70% | -242.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
| 30 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
| 60 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
| 90 Days Ago | -0.05 | -0.02 | -0.38 | 0.35 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TXMD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | 17.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 8/17/2023 |
| Reiterates | Cantor Fitzgerald: Neutral | 7/13/2022 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 6/7/2022 |
Related Tickers
MITRA.BR Mithra Pharmaceuticals SA
0.2200
-0.68%
TLPH Talphera, Inc.
1.1100
+14.43%
GHSI Guardion Health Sciences, Inc.
8.14
+3.04%
EVOK Evoke Pharma, Inc.
0.4390
-1.90%
ENDPQ Endo International plc
0.0000
-99.83%
DN.TO Delta 9 Cannabis Inc.
0.0250
0.00%
DRRX DURECT Corporation
0.8711
-1.40%
GRNF GRN Holding Corporation
0.0710
0.00%
WRHLF Love Hemp Group Plc
0.0000
0.00%
CLVRW Clever Leaves Holdings Inc.
0.0400
0.00%